Mutual of America Capital Management’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-3,587
Closed -$53K 1545
2022
Q3
$53K Buy
3,587
+539
+18% +$10.7K ﹤0.01% 1601
2022
Q2
$83K Buy
3,048
+488
+19% +$14.5K ﹤0.01% 1539
2022
Q1
$97K Buy
2,560
+133
+5% +$5.89K ﹤0.01% 1522
2021
Q4
$151K Buy
+2,427
New +$184K ﹤0.01% 1425

Other funds holding OPRX

Mutual of America Capital Management's OPRX Position: Q4 2022 in Review

Mutual of America Capital Management sold out of OptimizeRx (OPRX) in Q4 2022, closing a stake of 3,587 shares — an estimated $53K sold.

Mutual of America Capital Management first reported a position in OPRX in Q4 2021 and held it in 4 quarters. The position peaked at $151K in Q4 2021. 129 funds tracked by Wall St. Rank hold OPRX as of Q4 2022.

  • Mutual of America Capital Management reported no remaining OptimizeRx position as of Q4 2022 after selling out during the quarter.
  • Mutual of America Capital Management sold 3,587 OptimizeRx shares in Q4 2022, an estimated $53K.
  • Mutual of America Capital Management first reported a position in OptimizeRx in Q4 2021 and held it in 4 quarters.
  • Mutual of America Capital Management's OptimizeRx position peaked at $151K in Q4 2021.
  • 129 funds tracked by Wall St. Rank held OptimizeRx as of Q4 2022.

Based on Mutual of America Capital Management's 13F filing for Q4 2022, filed 10 Feb 2023.